Clinical Trial Update: Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of NK012 with 5-FU/leucovorin in advanced solid tumors, with planned dose expansion in colorectal cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-FU/LV (5-fluorouracil with leucovorin)
• NK012 (NK012)

Snippet

Sponsor: Nippon Kayaku Co., Ltd. | Conditions: Advanced Solid Tumors, Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED